BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  Surprise! FDA Clears Launch For Portola’s Potential Multibillion-Dollar Drug Next Month

  The FDA continues to hand out some early Christmas presents to pharma companies.

  December 19, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  BioCapital

  Maryland’s Precision Medicine Group Lands $275M

  The round was led by Berkshire Partners and TPG Growth, with participation from its co-founders and management team, as well as original investors Oak Investment Partners and J.H. Whitney.

  December 19, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  The Wait Continues: TherapeuticsMD Gets New Timeline for FDA Review For Its Drug

  The FDA has acknowledged that the resubmission is a complete, class 2 response to the CRL received on May 5, 2017 for TX-004HR.

  December 19, 2017

   · 

  2 min read

   · 

  Mark Terry